The Effect of Bezafibrate on Cholestatic Itch

PHASE3UnknownINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

April 30, 2018

Conditions
Primary Biliary CholangitisPrimary Sclerosing CholangitisSecondary Sclerosing Cholangitis
Interventions
DRUG

Bezafibrate

bezafibrate 400mg per day

DRUG

Placebo

placebo 400mg per day

Trial Locations (9)

Unknown

RECRUITING

Academic Medical Center, Amsterdam

RECRUITING

Vrije Universiteit Medisch Centrum, Amsterdam

RECRUITING

Universitair Medisch Centrum Groningen, Groningen

RECRUITING

Leids Universitair Medisch Centrum, Leiden

RECRUITING

Maastricht Universitair Medisch Centrum, Maastricht

RECRUITING

Radboud Universitair Medisch Centrum, Nijmegen

RECRUITING

Erasmus Medisch Centrum, Rotterdam

RECRUITING

Universitair Medisch Centrum Utrecht, Utrecht

NOT_YET_RECRUITING

University of Barcelona, Barcelona

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

collaborator

University Medical Center Groningen

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

UMC Utrecht

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

Maastricht University Medical Center

OTHER

collaborator

Free University Medical Center

OTHER

collaborator

University of Barcelona

OTHER

collaborator

Ludwig-Maximilians - University of Munich

OTHER

collaborator

Friedrich-Alexander-Universität Erlangen-Nürnberg

OTHER

collaborator

Istituto Clinico Humanitas

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT02701166 - The Effect of Bezafibrate on Cholestatic Itch | Biotech Hunter | Biotech Hunter